Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, April 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 56 articles:
HTML format


 

Single Articles

  1. BRANCALE A, Shailubhai K, Ferla S, Ricci A, et al
    Therapeutically targeting guanylate cyclase-C: computational modeling of plecanatide, a uroguanylin analog.
    Pharmacol Res Perspect. 2017;5:e00295.
    Abstract    

    Abstract available

  2. IBRAHIM NK, Al-Bloushy RI, Sait SH, Al-Azhary HW, et al
    Irritable bowel syndrome among nurses working in King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
    Libyan J Med. 2016;11:30866.
    Abstract    

    Abstract available

  3. ABRAHAMSSON TR, Wu RY, Sherman PM
    Microbiota in Functional Gastrointestinal Disorders in Infancy: Implications for Management.
    Nestle Nutr Inst Workshop Ser. 2017;88:107-115.
    Abstract    

    Abstract available

  4. RUTTEN JM, Vlieger AM, Frankenhuis C, George EK, et al
    Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.
    JAMA Pediatr. 2017 Mar 27. doi: 10.1001/jamapediatrics.2017.0091.
    Abstract    

    Abstract available

  5. ESWARAN S
    Low FODMAP in 2017: Lessons learned from clinical trials and mechanistic studies.
    Neurogastroenterol Motil. 2017;29.
    Abstract    

    Abstract available

  6. JUSZCZUK K, Grudlewska K, Mikucka A, Gospodarek E, et al
    Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
    Postepy Hig Med Dosw (Online). 2017;71:220-226.
    Abstract    

    Abstract available

  7. BUONO JL, Mathur K, Averitt AJ, Andrae DA, et al
    Economic Burden of Irritable Bowel Syndrome with Diarrhea: Retrospective Analysis of a U.S. Commercially Insured Population.
    J Manag Care Spec Pharm. 2017;23:453-460.
    Abstract    

    Abstract available

  8. YAO CK, Tuck CJ, Barrett JS, Canale KE, et al
    Poor reproducibility of breath hydrogen testing: Implications for its application in functional bowel disorders.
    United European Gastroenterol J. 2017;5:284-292.
    Abstract    

    Abstract available

  9. MELCHIOR C, Aziz M, Aubry T, Gourcerol G, et al
    Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study.
    United European Gastroenterol J. 2017;5:261-269.
    Abstract    

    Abstract available

  10. ERICKSON J, Wang Q, Slavin J
    White Grape Juice Elicits a Lower Breath Hydrogen Response Compared with Apple Juice in Healthy Human Subjects: A Randomized Controlled Trial.
    J Acad Nutr Diet. 2017 Mar 22. pii: S2212-2672(17)30102.
    Abstract    

    Abstract available

  11. SZNURKOWSKA K, Zawrocki A, Sznurkowski J, Izycka-Swieszewska E, et al
    Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
    J Biol Regul Homeost Agents. 2017;31:125-131.
    Abstract    

    Abstract available

  12. BALEMANS D, Boeckxstaens GE, Talavera K, Wouters MM, et al
    Transient Receptor Potential Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades Underlying Visceral Hypersensitivity.
    Am J Physiol Gastrointest Liver Physiol. 2017 Apr 6:ajpgi.00401.2016.
    Abstract    

    Abstract available

  13. HARVIE DS, Moseley GL, Hillier SL, Meulders A, et al
    Classical conditioning differences associated with chronic pain: a systematic review.
    J Pain. 2017 Apr 3. pii: S1526-5900(17)30484-4. doi: 10.1016/j.jpain.2017.
    Abstract    

    Abstract available

  14. SIDDIQUI S, Misra SP, Dwivedi M, Pant S, et al
    Irritable Bowel Syndrome and Bronchial Asthma: Are They Associated in Indian Population?
    J Clin Diagn Res. 2017;11:OC21-OC23.
    Abstract    

    Abstract available

  15. YANG TY, Chen CS, Lin CL, Lin WM, et al
    Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database Study.
    Medicine (Baltimore). 2017;96:e6657.
    Abstract    

    Abstract available

  16. SIDHU M, van der Poorten D
    The gut microbiome.
    Aust Fam Physician. 2017;46:206-211.
    Abstract    

    Abstract available

  17. MEURET AE, Kroll J, Ritz T
    Panic Disorder Comorbidity with Medical Conditions and Treatment Implications.
    Annu Rev Clin Psychol. 2017 Mar 27. doi: 10.1146/annurev-clinpsy-021815-093044.
    Abstract    

    Abstract available

  18. LACY BE
    Hot Topics in Primary Care: Role of the Microbiome in Disease: Implications for Treatment of Irritable Bowel Syndrome.
    J Fam Pract. 2017;66.
    Abstract    

    Abstract available

  19. OSTERTAG D, Annahazi A, Krueger D, Michel K, et al
    Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients.
    Neurogastroenterol Motil. 2017 Apr 4. doi: 10.1111/nmo.13070.
    Abstract    

    Abstract available

  20. SIMREN M, Palsson OS, Whitehead WE
    Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice.
    Curr Gastroenterol Rep. 2017;19:15.
    Abstract    

    Abstract available

  21. ANDREOLI L, Tincani A
    Undifferentiated connective tissue disease, fibromyalgia and the environmental factors.
    Curr Opin Rheumatol. 2017 Mar 31. doi: 10.1097/BOR.0000000000000392.
    Abstract    

    Abstract available

  22. ERBASAN F, Cekin Y, Coban DT, Karasu U, et al
    The Frequency of Primary Sjogren's Syndrome and Fibromyalgia in Irritable Bowel Syndrome.
    Pak J Med Sci. 2017;33:137-141.
    Abstract    

    Abstract available

  23. ALAQEEL MK, Alowaimer NA, Alonezan AF, Almegbel NY, et al
    Prevalence of Irritable Bowel Syndrome and its Association with Anxiety among Medical Students at King Saud bin Abdulaziz University for Health Sciences in Riyadh.
    Pak J Med Sci. 2017;33:33-36.
    Abstract    

    Abstract available

  24. ISHIMOTO H, Oshima T, Sei H, Yamasaki T, et al
    Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients.
    J Clin Biochem Nutr. 2017;60:146-150.
    Abstract    

    Abstract available

  25. AGGER JL, Schroder A, Gormsen LK, Jensen JS, et al
    Imipramine versus placebo for multiple functional somatic syndromes (STreSS-3): a double-blind, randomised study.
    Lancet Psychiatry. 2017 Apr 10. pii: S2215-0366(17)30126.
    Abstract    

    Abstract available

  26. FEHNEL SE, Ervin CM, Carson RT, Rigoni G, et al
    Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Value Health. 2017;20:618-626.
    Abstract    

    Abstract available

  27. NGUYEN TT, Dau DT, Nguyen DC, Nguyen HT, et al
    Effects of Trang Phuc Linh Plus-Food Supplement on Irritable Bowel Syndrome Induced by Mustard Oil.
    J Med Food. 2017;20:385-391.
    Abstract    

    Abstract available

  28. FLIK CE, Bakker L, Laan W, van Rood YR, et al
    Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome.
    World J Gastroenterol. 2017;23:2223-2233.
    Abstract    

    Abstract available

  29. HOLTMANN GJ, Ford AC, Talley NJ
    Pathophysiology of irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2016;1:133-146.
    Abstract    

    Abstract available

  30. LE GAL J, Michel JF, Rinaldi VE, Spiri D, et al
    Association between functional gastrointestinal disorders and migraine in children and adolescents: a case-control study.
    Lancet Gastroenterol Hepatol. 2016;1:114-121.
    Abstract    

    Abstract available

  31. SIMREN M, Tornblom H, Palsson OS, Whitehead WE, et al
    Management of the multiple symptoms of irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2017;2:112-122.
    Abstract    

    Abstract available

  32. CHUTIMA R, Kanchanatawan B, Sirivichayakul S, Anderson G, et al
    IgA/IgM Responses to Gram-Negative Bacteria are not Associated with Perinatal Depression, but with Physio-Somatic Symptoms and Activation of the Tryptophan Catabolite Pathway at the End of Term and Postnatal Anxiety.
    CNS Neurol Disord Drug Targets. 2017.
    Abstract    

    Abstract available

  33. TSIGARIDAS A, Papanikolaou IS, Vaiopoulou A, Anagnostopoulos AK, et al
    Proteomics and Irritable Bowel Syndrome.
    Expert Rev Proteomics. 2017 Apr 11. doi: 10.1080/14789450.2017.1317600.
    Abstract    

    Abstract available

  34. CHEN CY, Zhang M, Wang SS, Lu B, et al
    [Changes of adherens junctions between the epithelial cells of intestinal mucosal barrier in irritable bowel syndrome].
    Zhonghua Yi Xue Za Zhi. 2017;97:1065-1070.
    Abstract    

    Abstract available

  35. DINDO L, Lackner J
    The impact of different coping strategies on the physical and mental health of irritable bowel syndrome patients.
    Clin Gastroenterol Hepatol. 2017 Apr 6. pii: S1542-3565(17)30396.
    Abstract    



  36. FUKE N, Aizawa K, Suganuma H, Takagi T, et al
    Effect of combined consumption of Lactobacillus brevis KB290 and beta-carotene on minor diarrhoea-predominant irritable bowel syndrome-like symptoms in healthy subjects: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Int J Food Sci Nutr. 2017 Apr 9:1-14. doi: 10.1080/09637486.2017.1311843.
    Abstract    

    Abstract available

  37. MARTINEZ KB, Leone VA, Chang EB
    Microbial Metabolites in Health and Disease: Navigating the Unknown in Search of Function.
    J Biol Chem. 2017 Apr 7. pii: jbc.R116.752899. doi: 10.1074/jbc.R116.752899.
    Abstract    

    Abstract available

  38. MADISCH A, Vinson BR, Abdel-Aziz H, Kelber O, et al
    Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Wien Med Wochenschr. 2017 Apr 19. doi: 10.1007/s10354-017-0557.
    Abstract    

    Abstract available

  39. SUNDIN J, Ohman L, Simren M
    Understanding the Gut Microbiota in Inflammatory and Functional Gastrointestinal Diseases.
    Psychosom Med. 2017 Apr 18. doi: 10.1097/PSY.0000000000000470.
    Abstract    

    Abstract available

  40. BAYLESS TM, Brown E, Paige DM
    Lactase Non-persistence and Lactose Intolerance.
    Curr Gastroenterol Rep. 2017;19:23.
    Abstract    

    Abstract available

  41. HILL P, Muir JG, Gibson PR
    Controversies and Recent Developments of the Low-FODMAP Diet.
    Gastroenterol Hepatol (N Y). 2017;13:36-45.
    Abstract    

    Abstract available

  42. PARK YM, Lee YJ, Hussain Z, Lee YH, et al
    The effects and mechanism of action of methane on ileal motor function.
    Neurogastroenterol Motil. 2017 Apr 18. doi: 10.1111/nmo.13077.
    Abstract    

    Abstract available

  43. CHAI Y, Huang Y, Tang H, Tu X, et al
    Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome.
    Exp Ther Med. 2017;13:1187-1193.
    Abstract    

    Abstract available

  44. COMPARE D, Rocco A, Coccoli P, Angrisani D, et al
    Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.
    BMC Gastroenterol. 2017;17:53.
    Abstract    

    Abstract available

  45. HELLSTROM O
    [Not Available].
    Lakartidningen. 2016;113.
    Abstract    



  46. REED-KNIGHT B, Claar RL, Schurman JV, van Tilburg MA, et al
    Implementing psychological therapies for functional GI disorders in children and adults.
    Expert Rev Gastroenterol Hepatol. 2016;10:981-4.
    Abstract    

    Abstract available

  47. QUIGLEY EM
    Editorial: diet, inflammation and irritable bowel syndrome.
    Aliment Pharmacol Ther. 2017;45:1278-1279.
    Abstract    



  48. LACY BE, Chey WD, Cash BD, Lembo AJ, et al
    Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    Abstract    

    Abstract available

  49. CHOGHAKHORI R, Abbasnezhad A, Amani R, Alipour M, et al
    Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4554.
    Abstract    

    Abstract available

  50. BALLOU S, Keefer L
    Development of the Irritable Bowel Syndrome Cognitive Affective Scale: a brief self-report measure for clinical and research settings.
    Eur J Gastroenterol Hepatol. 2017 Mar 23. doi: 10.1097/MEG.0000000000000872.
    Abstract    

    Abstract available

  51. SOOD R, Ford AC
    Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From Health.
    Gastroenterology. 2016;151:1245-1246.
    Abstract    



  52. DAI C, Jiang M, Sun MJ
    Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Gastroenterology. 2017 Apr 1. pii: S0016-5085(17)30220.
    Abstract    



  53. BENNET SMP, Bohn L, Storsrud S, Liljebo T, et al
    Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs.
    Gut. 2017 Apr 17. pii: gutjnl-2016-313128. doi: 10.1136/gutjnl-2016-313128.
    Abstract    

    Abstract available

  54. BONVANIE IJ, Kallesoe KH, Janssens KAM, Schroder A, et al
    Psychological Interventions for Children with Functional Somatic Symptoms: A Systematic Review and Meta-Analysis.
    J Pediatr. 2017 Apr 14. pii: S0022-3476(17)30366.
    Abstract    

    Abstract available

  55. EL-SALHY M, Patcharatrakul T, Hatlebakk JG, Hausken T, et al
    Chromogranin A cell density in the large intestine of Asian and European patients with irritable bowel syndrome.
    Scand J Gastroenterol. 2017 Mar 27:1-7. doi: 10.1080/00365521.2017.1305123.
    Abstract    

    Abstract available

  56. KATO T, Honda Y, Kurita Y, Iwasaki A, et al
    Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers.
    PLoS One. 2017;12:e0175626.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;